The 11β-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action

European Journal of Biochemistry

Volumn 249, Issue 2, 1997, Pages 361-364

  Seckl, Jonathan R ^a   Chapman, Karen E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 dehydrocorticosterone; 11 hydroxysteroid dehydrogenase; Apparent mineralocorticoid excess; Corticosterone; Cortisol; Cortisone; Fetal programming; Glucocorticoid receptor; Hypertension; Mineralocorticoid receptor

Indexed keywords

11 HYDROXYCORTICOSTEROID; 11BETA HYDROXYSTEROID DEHYDROGENASE; ISOENZYME; MINERALOCORTICOID; OXIDOREDUCTASE; GLUCOCORTICOID; HYDROXYSTEROID DEHYDROGENASE;

ENZYME ACTIVITY; FETUS; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; HYPOKALEMIA; MUTATION; NEPHRON; ONTOGENY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; ENZYME SPECIFICITY; ENZYMOLOGY; FEMALE; GENETICS; INBORN ERROR OF METABOLISM; METABOLISM; PHYSIOLOGY; PREGNANCY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; FEMALE; FETUS; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; METABOLISM, INBORN ERRORS; MINERALOCORTICOIDS; PLACENTA; PREGNANCY; SUBSTRATE SPECIFICITY;

EID: 0031572620     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.t01-1-00361.x     Document Type: Review

References (42)

1. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily, Science 240, 889-895.
2. Edwards, C. R. W., Stewart, P. M., Burt, D., Brett, L., McIntyre, M. A., Sutanto, W. S., de Kloet, E. R. & Monder, C. (1988) Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor, Lancet ii, 986-989.
3. Funder, J. W., Pearce, P. T., Smith, R. & Smith, A. I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated, Science 242, 583-585.
4. Siewart, P. M., Corrie, J. E. T., Shackleton, C. H. L. & Edwards, C. W. (1988) Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle, J. Clin. Invest. 82, 340-349.
5. Stewart, P. M., Valentino, R., Wallace, A. M., Burl, D., Shackleton, C. H. L. & Edwards, C. R. W. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age, Lancet ii, 821-824.
6. Mune, T., Rogerson, F. M., Nikkilä, H., Agurwal, A. K. & White, P. C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase, Nat. Genet. 10, 394-399.
7. Soro, A., Ingram, M. C., Tonolo, G., Glorioso, N. & Fraser, R. (1995) Evidence of coexisting changes in 11beta-hydroxysteroid dehydrogenase and 5beta-reductase activity in subjects with untreated essential hypertension, Hypertension 25, 67-70.
8. White, P. C., Mune, T. & Agurwal, A. K. (1997) 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess, Endocrine Rev. 18, 135-156.
9. Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L. & Edwards, C. R. W. (1993) Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension, Clin. Endocrinol. 38, 221-227.
10. Watson, B. Jr. Bergman, S. M., Myracle, A., Callen, D. F., Acton, R. T. & Warnock, D. G. (1996) Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks, Hypertension 28, 478-482.
11. Mune, T. & White, P. C. (1996) Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype, Hypertension 27, 1193-1199.
12. Murphy, B. E. P., Clark, S. J., Donald, I. R., Pinsky, M. & Vedady, D. L. (1974) Conversion of maternal cortisol to cortisone during placental transfer to the human fetus, Am. J. Obstet. Gynecol. 118, 538-541.
13. Stewart, P. M., Murry, B. A. & Mason, J. I. (1994) Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues, J. Clin. Endocrinol. Metab. 78, 1529-1532.
14. Brown, R. W., Diaz, R., Robson, A. C., Kotolevtsev, Y., Mullins, J. J., Kaufman, M. H. & Seckl, J. R. (1996) The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development, Endocrinology 137, 794-797.
15. Benediktsson, R., Calder, A. A., Edwards, C. R. W. & Seckl, J. R. (1997) Placental 11β-hydroxysteroid dehydrogenase type 2 is the placental harrier to maternal glucocorticoids: ex vivo studies, Clin. Endocrinol. 46, 161-166.
16. Seckl, J. R. (1997) Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2 and the early life origins of adult disease, Steroids 62, 89-94.
17. Benediktsson, R., Lindsay, R., Noble, J., Seckl, J. R. & Edwards, C. R. W. (1993) Glucocorticoid exposure in utero: a new model for adult hypertension, Lancet 341, 339-341.
18. Lindsay, R. S., Lindsay, R. M., Edwards, C. R. W. & Seckl, J. R. (1996) Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring, Hypertension 27, 1200-1204.
19. Lindsay, R. S., Lindsay, R. M., Waddell, B. & Seckl, J. R. (1996) Programming of glucose tolerance in the rat: role of placental 11β-hydroxysteroid dehydrogenase, Diabetologia 39, 1299-1305.
20. Barker, D. J. P. (1994) Mothers, babies and disease in later life, BMJ Publishing Group, London.
21. Stewart, P. M., Rogerson, F. M. & Mason, J. I. (1995) Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis, J. Clin. Endocrinol. Metab. 80, 885-890.
22. Kotelevtsev, Y. V., Jamieson, P. M., Best, R., Stewart, F., Edwards, C. R. W., Seckl, J. R. & Mullins, J. J. (1996) Inactivation of 11β-hydroxysteroid dehydrogenase type 1 by gene targeling in mice, Endocr. Res. 22, 791-792.
23. Seckl, J. R. (1997) 11β-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front. Neuroendocrinol. 18, 49-99.
24. Walker, B. R., Connacher, A. A., Lindsay, R. M., Webb, D. J. & Edwards, C. R. W. (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel rule for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation, J. Clin. Endocrinol. Metab. 80, 3155-3159.
25. Bujalska, I., Kumar, S. & Stewart, P. M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349, 1210-1213.
26. Phillipov, G., Palermo, M. & Shackleton, C. H. L. (1996) Apparent cortisone reductase deficiency: A unique form of hypercortisolism, J. Clin. Endocrinol. Metab. 81, 3855-3860.
27. Seckl, J. R. (1993) 11β-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation, Eur. J. Clin. Invest. 23, 589-601.
28. Moisan, M.-P., Edwards, C. R. W. & Seckl, J. R. (1992) Differential promoter usage by the rat 11β-hydroxysteroid dehydrogenase gene, Mol. Endocrinol. 6, 1082-1087.
29. Obeid, J., Curnow, K. M., Aisenberg, J. & White, P. C. (1993) Transcripts originating in intron 1 of the HSD11 (11β-hydroxysteroid dehydrogenase) gene encode a truncated polypeptide that is enzymatically inactive, Mol. Endocrinol. 7, 154-160.
30. Low, S. C., Chapman, K. E., Edwards, C. R. W., Wells, T., Robinson, I. C. A. F. & Seckl, J. R. (1994) Female pattern growth hormone secretion mediates the oestrogen-related decrease in hepatic 11β-hydroxysteroid dehydrogenase expression in the rat, J. Endocrinol. 143, 541-548.
31. Voice, M., Seckl, J. R., Edwards, C. R. W. & Chapman, K. E. (1996) 11β-hydroxysteroid dehydrogenase type 1 expression in 2S-FAZA hepatoma cells is hormonally-regulated: a model for the study of hepatic corticosteroid metabolism, Biochem. J. 317, 621-625.
32. Chapman, K. H., Kotelevstev, Y. V., Jamieson, P. M., Williams, L. J. S., Mullins, J. J. & Seckl, J. R. (1997) Tissue-specific modulation of glucocorticoid action by the 11β-hydroxysteroid dehydrogenases, Biochem. Soc. Trans. 25, 583-587.
33. Waddell, B., Benediktsson, R. & Seckl, J. R. (1996) 11β-hydroxysteroid dehydrogenase type 2 in the rat corpus luteum: induction of mRNA expression and bioactivity coincident with luteal regression, Endocrinology 137, 5386-5391.
34. Pepe, G. J., Babischkin, J. S., Burch, M. G., Leavitt, M. G. & Albrecht, E. D. (1996) Developmental increase in expression of the messenger ribonucleic acid and protein levels of 11β-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta, Endocrinology 137, 5678-5684.
35. Agarwal, A. K. & White, P. C. (1996) Analysis of the promoter of the NAD + dependent 11β-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells. Mol. Cell. Endocrinol. 121, 93-99.
36. Monder, C. & White, P. C. (1993) 11β-hydroxysteroid dehydrogenase, Vit. Horm. 47, 187-271.
37. Roland, B. L., Li, K. X. Z., & Funder, J. W. (1995) Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain, Endocrinology 136, 4697-4700.
38. Michael, A. E., Gregory, L., Walker, S. M., Antoniw, J. W., Shaw, R. W., Edwards, C. R. W. & Cooke, B. A. (1993) Ovarian 11β-hydroxysteroid dehydrogenase: potential predictor of conception by in vitro fertilisation and embryo transfer, Lancet 342, 711-712.
39. Monder, C., Miroff, Y., Marandici, A. & Hardy, M. P. (1994) 11β-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells, Endocrinology 134, 1199-1204.
40. Hennebold, J. D., Ryu, S. Y., Mu, H. H., Galbraith, A. & Daynes, R. A. (1996) 11β-Hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs, Am. J. Physiol. 270, R1296-R1306.
41. Hennebold, J. D., Mu, H. H., Poynter, M. E., Chen, X. P. & Daynes, R. A. (1997) Active cataholism of glucocorticoids by 11β-hydroxysteroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes, Int. Immunol. 9, 105-115.
42. Baker, R. W., Zumla, A. & Rook, G. A. W. (1996) Tuberculosis, steroid metabolism and immunity, Q. J. Med. 89, 387-394.